Sonal Singh to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Sonal Singh has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.967
-
Singh S, Nautiyal A, Belk KW. Real World Outcomes Associated with Idarucizumab: Population-Based Retrospective Cohort Study. Am J Cardiovasc Drugs. 2020 Apr; 20(2):161-168.
Score: 0.567
-
Li X, Singh S, DeVries A, Gurwitz JH. Lecanemab Therapy Use Patterns for Alzheimer's Disease Among Early Initiators in a Large National Health Plan. J Am Geriatr Soc. 2025 Oct; 73(10):3203-3207.
Score: 0.205
-
Cabrera-Perez JS, Carey VJ, Odejide OO, Singh S, Kupper TS, Pillai SS, Weiss ST, Akenroye A. Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy. J Allergy Clin Immunol. 2025 May; 155(5):1584-1594.
Score: 0.195